Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study
Jeffrey M Beckett1, Neeraj K Singh1, Jehan Phillips2
1School of Health Sciences, University of Tasmania, Launceston, TAS 7250, Australia.
Nutrients
|June 24, 2020
Summary
This pilot study found that prebiotic sugarcane flour significantly reduced heartburn and total symptoms in GERD patients. Further research is recommended to confirm these positive effects on gastroesophageal reflux disease management.
Area of Science:
- Gastroenterology
- Dietary interventions
- Clinical nutrition
Background:
- Gastroesophageal reflux disease (GERD) impacts 20% of Australians, characterized by heartburn from stomach acid reflux.
- Anecdotal evidence suggests prebiotic sugarcane flour may alleviate GERD symptoms.
- A pilot study was conducted to investigate sugarcane flour's efficacy in GERD patients.
Purpose of the Study:
- To evaluate the effectiveness of prebiotic sugarcane flour in reducing GERD symptoms.
- To assess changes in heartburn, regurgitation, and overall quality of life in GERD patients.
Main Methods:
- A single-center, double-blinded, placebo-controlled randomized trial with 43 participants.
- Intervention group received 3g daily sugarcane flour; control group received 3g daily cellulose placebo.
- Symptoms were assessed using the GERD-HRQL questionnaire over three weeks.
Main Results:
- Sugarcane flour significantly reduced heartburn and total GERD symptoms (p < 0.05).
- The placebo group showed increased scores for regurgitation and total symptoms.
- No significant changes were observed in the placebo group for heartburn.
Conclusions:
- Prebiotic sugarcane flour demonstrated significant positive effects in reducing GERD symptoms.
- The findings support further investigation with a larger randomized controlled trial.
- Sugarcane flour shows potential as a therapeutic option for GERD symptom management.
More Related Videos
Related Concept Videos
Blind Procedures
12.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.7K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
445
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
445
The Placebo Effect
6.7K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.7K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.1K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.1K
Gastroesophageal Reflux Disease II: Clinical Features and Management
580
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
580
Oral Hypoglycemic Agents: Biguanides and Glitazones
515
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
515


![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)